These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4374063)

  • 21. What is the advantage of having melanin in parts of the central nervous system (e.g. substantia nigra)?
    Costin GE
    IUBMB Life; 2004 Jan; 56(1):47-9. PubMed ID: 14992380
    [No Abstract]   [Full Text] [Related]  

  • 22. [Histochemistry of monoamine metabolism].
    Shimizu N
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):851-8. PubMed ID: 4898005
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
    Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double KL
    Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of the iron-neuromelanin system in Parkinson's disease.
    Fasano M; Bergamasco B; Lopiano L
    J Neurochem; 2006 Feb; 96(4):909-16. PubMed ID: 16417570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra.
    Aime S; Fasano M; Bergamasco B; Lopiano L; Valente G
    J Neurochem; 1994 Jan; 62(1):369-71. PubMed ID: 8263538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.
    Enochs WS; Nilges MJ; Swartz HM
    J Neurochem; 1993 Jul; 61(1):68-79. PubMed ID: 8390568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry.
    Horga G; Wengler K; Cassidy CM
    JAMA Psychiatry; 2021 Jul; 78(7):788-789. PubMed ID: 34009285
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunofluorescence cytochemistry on thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B: a pilot study.
    Moll G; Moll R; Riederer P; Gsell W; Heinsen H; Denney RM
    J Neural Transm Suppl; 1990; 32():67-77. PubMed ID: 2089113
    [No Abstract]   [Full Text] [Related]  

  • 30. [Differential depletion of storage sites for noradrenalin, dopamine and serotonin by oxypertin].
    Hassler R; Bak IJ; Kim JS
    Nervenarzt; 1970 Mar; 41(3):105-18. PubMed ID: 5447883
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.
    Aime S; Bergamasco B; Casu M; Digilio G; Fasano M; Giraudo S; Lopiano L
    Mov Disord; 2000 Sep; 15(5):977-81. PubMed ID: 11009208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the extraneuronal nature of cardiac monoamine oxidase in the rat.
    Horita A; Lowe MC
    Adv Biochem Psychopharmacol; 1972; 5():227-42. PubMed ID: 5054204
    [No Abstract]   [Full Text] [Related]  

  • 33. Cysteinyldopamine is not incorporated into neuromelanin.
    Wakamatsu K; Ito S; Nagatsu T
    Neurosci Lett; 1991 Sep; 131(1):57-60. PubMed ID: 1791980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Melanoma].
    Seiji M
    Tanpakushitsu Kakusan Koso; 1970 Apr; 15(5):550-9. PubMed ID: 4987916
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuromelanin in the substantia nigra of adult horses.
    Cozzi B; Pellegrini M; Droghi A
    Anat Anz; 1988; 166(1-5):53-61. PubMed ID: 3189848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The histochemical relationship of neuromelanin and lipofuscin.
    Barden H
    J Neuropathol Exp Neurol; 1969 Jul; 28(3):419-41. PubMed ID: 4978022
    [No Abstract]   [Full Text] [Related]  

  • 37. The molecular mechanisms of dopamine toxicity.
    Barzilai A; Daily D; Zilkha-Falb R; Ziv I; Offen D; Melamed E; Shirvan A
    Adv Neurol; 2003; 91():73-82. PubMed ID: 12442665
    [No Abstract]   [Full Text] [Related]  

  • 38. Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients.
    Lopiano L; Chiesa M; Digilio G; Giraudo S; Bergamasco B; Torre E; Fasano M
    Biochim Biophys Acta; 2000 Mar; 1500(3):306-12. PubMed ID: 10699372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue binding of tritiated norepinephrine in pigmented nuclei of human brain.
    Ishii T; Friede RL
    Am J Anat; 1968 Jan; 122(1):139-44. PubMed ID: 5654500
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical aspects of schizophrenia.
    Lewis ME
    Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.